These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25605813)

  • 1. Impact on creatinine renal clearance by the interplay of multiple renal transporters: a case study with INCB039110.
    Zhang Y; Warren MS; Zhang X; Diamond S; Williams B; Punwani N; Huang J; Huang Y; Yeleswaram S
    Drug Metab Dispos; 2015 Apr; 43(4):485-9. PubMed ID: 25605813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tucatinib Inhibits Renal Transporters OCT2 and MATE Without Impacting Renal Function in Healthy Subjects.
    Topletz-Erickson AR; Lee AJ; Mayor JG; Rustia EL; Abdulrasool LI; Wise AL; Dailey B; DeChenne S; Walker LN; Alley SC; Endres CJ
    J Clin Pharmacol; 2021 Apr; 61(4):461-471. PubMed ID: 32989831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.
    Lepist EI; Zhang X; Hao J; Huang J; Kosaka A; Birkus G; Murray BP; Bannister R; Cihlar T; Huang Y; Ray AS
    Kidney Int; 2014 Aug; 86(2):350-7. PubMed ID: 24646860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of changes in serum creatinine and creatinine clearance caused by renal transporter inhibition in healthy subjects.
    Nakada T; Kudo T; Kume T; Kusuhara H; Ito K
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):233-238. PubMed ID: 31176593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of
    Miyake T; Mizuno T; Takehara I; Mochizuki T; Kimura M; Matsuki S; Irie S; Watanabe N; Kato Y; Ieiri I; Maeda K; Ando O; Kusuhara H
    Drug Metab Dispos; 2019 Nov; 47(11):1270-1280. PubMed ID: 31511257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine.
    Mathialagan S; Rodrigues AD; Feng B
    J Pharm Sci; 2017 Sep; 106(9):2535-2541. PubMed ID: 28416419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.
    Omote S; Matsuoka N; Arakawa H; Nakanishi T; Tamai I
    Sci Rep; 2018 Jun; 8(1):9237. PubMed ID: 29915248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
    Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
    Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
    Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
    Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression.
    Shen H; Liu T; Morse BL; Zhao Y; Zhang Y; Qiu X; Chen C; Lewin AC; Wang XT; Liu G; Christopher LJ; Marathe P; Lai Y
    Drug Metab Dispos; 2015 Jul; 43(7):984-93. PubMed ID: 25904762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?
    Chu X; Bleasby K; Chan GH; Nunes I; Evers R
    Drug Metab Dispos; 2016 Sep; 44(9):1498-509. PubMed ID: 26825641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis.
    Bissonnette R; Luchi M; Fidelus-Gort R; Jackson S; Zhang H; Flores R; Newton R; Scherle P; Yeleswaram S; Chen X; Menter A
    J Dermatolog Treat; 2016 Aug; 27(4):332-8. PubMed ID: 26769332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
    Doki K; Apáti S; Sakata T; Homma M
    Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion.
    Imamura Y; Murayama N; Okudaira N; Kurihara A; Okazaki O; Izumi T; Inoue K; Yuasa H; Kusuhara H; Sugiyama Y
    Clin Pharmacol Ther; 2011 Jan; 89(1):81-8. PubMed ID: 21124314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular secretion of pramipexole.
    Knop J; Hoier E; Ebner T; Fromm MF; Müller F
    Eur J Pharm Sci; 2015 Nov; 79():73-8. PubMed ID: 26360835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs.
    George B; Wen X; Jaimes EA; Joy MS; Aleksunes LM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
    Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y
    Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.